[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369255-105":59,"doc-detail-369255-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","paired-primary-metastasis-patient-derived-organoids-and-mouse-models-identify-phenotypic-evolution-and-druggable-dependencies-of-peritoneal-metastasis-from-appendiceal-cancer-abstract","Paired primary-metastasis patient-derived organoids and mouse models identify phenotypic evolution and druggable dependencies of peritoneal metastasis from appendiceal cancer - abstract","","Peritoneal carcinomatosis is a common, deadly manifestation of gastrointestinal cancers with limited effective therapy. This study targets appendiceal adenocarcinoma (AC), which metastasizes predominantly to the peritoneum and differs genomically from colorectal cancer. The work creates a stable biobank of long-term cultured AC patient-derived organoids, including matched primary AC-peritoneal pairs, and an organoid orthotopic intraperitoneal xenograft model. Single-cell profiling and drug testing identify dedifferentiation and clinically actionable dependencies, including RMC-7977 and WNTinib.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/paired-primary-metastasis-patient-derived-organoids-and-mouse-models-identify-phenotypic-evolution-and-druggable-dependencies-of-peritoneal-metastasis-from-appendiceal-cancer-abstract/369255/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/paired-primary-metastasis-patient-derived-organoids-and-mouse-models-identify-phenotypic-evolution-and-druggable-dependencies-of-peritoneal-metastasis-from-appendiceal-cancer-abstract/369255.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",16,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"Why focus on appendiceal adenocarcinoma and peritoneal metastasis?","Question",{"text":113,"@type":114},"Appendiceal adenocarcinoma metastasizes almost exclusively to the peritoneum and has distinct genomic and mucinous features, while peritoneal carcinomatosis has poor survival and limited treatment options.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What models and resources are established in the study?",{"text":118,"@type":114},"The study builds a stable biobank of 16 long-term cultured AC patient-derived organoids with matched primary AC-peritoneal carcinomatosis pairs and an organoid orthotopic intraperitoneal xenograft model that reproduces diffuse peritoneal carcinomatosis.",{"name":120,"@type":111,"acceptedAnswer":121},"What key phenotypic and molecular changes are observed between primary and peritoneal states?",{"text":122,"@type":114},"Single-cell profiling shows dedifferentiation from mucinous differentiated states in primary AC into intestinal stem cell and fetal progenitor states in AC-PC, along with upregulation of oncogenic signaling pathways.",{"name":124,"@type":111,"acceptedAnswer":125},"Which drug-targeting strategies are identified as actionable?",{"text":126,"@type":114},"Hypothesis-driven drug testing highlights the KRAS multi-target inhibitor RMC-7977 and the Wnt-targeting tyrosine kinase inhibitor WNTinib as novel strategies to target AC-PC more effectively.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},369255,1790736726,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":144,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":149,"read_time":150,"preview_page_count":24,"preview_urls":151},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","bioRxiv preprint doi: [https://doi.org/10.1101/2025.02.17.638725](https://doi.org/10.1101/2025.02.17.638725); this version posted February 22, 2025. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made  \navailable under aCC-BY-NC 4.0 International license.  \nPaired primary-metastasis patient-derived organoids and mouse models identify phenotypic evolution and druggable dependencies of peritoneal metastasis from appendiceal cancer.  \nAhmed Mahmoud1,2 , Philip H. Choi2,3 , Christine Sukhwa2 , Jura Pintar2 , Henry Walch4,5,6 , Nan Zhao7 , Jonathan Bermeo2 , Sebastian Chung2,8 , Manisha Raghavan2,7 , Samhita Bapat2 , Qingwen Jiang2 , Georgios Karagkounis2,8 , Julia Meredith2 , Michael Giarrizzo2,8 , Canan Firat10 , Andrea Cercek3 , Michael B. Foote3 , Nikolaus Schultz11 , Walid K. Chatila 4 , Garrett M. Nash8 , Jinru Shia10 , Francisco Sanchez-Vega6,8 , Steven Larson2 , Arvin C. Dar7 , Neal Rosen2,3 , Karuna Ganesh2,3  \n1 Pharmacology Program, Weill Cornell Graduate School, New York, NY, USA  \n2 Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA  \n3 Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA  \n4 Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA  \n5 Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA 6 Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA 7 Program in Chemical Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA  \n8 Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA  \n9 Louis V. Gerstner Jr Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA  \n10 Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA  \nCorrespondence:  \nKaruna Ganesh, M. D. , Ph. D.  \nMemorial Sloan Kettering Cancer Center 1275 York Avenue  \nNew York  \nNY 10065  \nPhone: 646-888-3827  \nEmail: [ganeshk@mskcc.org](ganeshk@mskcc.org)  \nbioRxiv preprint doi: [https://doi.org/10.1101/2025.02.17.638725](https://doi.org/10.1101/2025.02.17.638725); this version posted February 22, 2025. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made  \navailable under aCC-BY-NC 4.0 International license.  \nSummary  \nPeritoneal carcinomatosis is a common yet deadly manifestation of gastrointestinal cancers, with few effective treatments. To identify targetable determinants of peritoneal metastasis, we focused on appendicealadenocarcinoma (AC), a gastrointestinal cancer that metastasizes almost exclusively to the peritoneum. Current treatments are extrapolated from colorectal cancer (CRC), yet AC has distinct genomic alterations, mucinous morphology and peritoneum restricted metastatic pattern. Further, no stable preclinical models of AC exist, limiting drug discovery and representing an unmet clinical need. We establish a first-in-class stable biobank of 16 long-term cultured AC patient-derived organoids (PDOs), including 3 matched, simultaneously resected primary AC-peritoneal carcinomatosis (AC-PC) pairs. By enriching for cancer cells, AC PDOs enable accurate genomic characterization relative to paucicellular AC tissue. We establish an organoid orthotopic intraperitoneal xenograft model that recapitulates diffuse peritoneal carcinomatosis and show that PC-organoids retain increased metastatic capacity, decreased growth factor dependency and sensitivity to standard of care chemotherapy relative to matched primary AC organoids. Single cell profiling of AC-PC pairs reveals dedifferentiation from mucin","cbCaipT0rzQY8tKz","https://ap.wps.com/l/cbCaipT0rzQY8tKz","pdf",9512620,43,"English","# Summary\n## Patient-derived organoids and matched pairs\n## Xenograft model and phenotypic changes\n## Single-cell profiling and pathway shifts\n## Hypothesis-driven drug testing","[{\"question\":\"Why focus on appendiceal adenocarcinoma and peritoneal metastasis?\",\"answer\":\"Appendiceal adenocarcinoma metastasizes almost exclusively to the peritoneum and has distinct genomic and mucinous features, while peritoneal carcinomatosis has poor survival and limited treatment options.\"},{\"question\":\"What models and resources are established in the study?\",\"answer\":\"The study builds a stable biobank of 16 long-term cultured AC patient-derived organoids with matched primary AC-peritoneal carcinomatosis pairs and an organoid orthotopic intraperitoneal xenograft model that reproduces diffuse peritoneal carcinomatosis.\"},{\"question\":\"What key phenotypic and molecular changes are observed between primary and peritoneal states?\",\"answer\":\"Single-cell profiling shows dedifferentiation from mucinous differentiated states in primary AC into intestinal stem cell and fetal progenitor states in AC-PC, along with upregulation of oncogenic signaling pathways.\"},{\"question\":\"Which drug-targeting strategies are identified as actionable?\",\"answer\":\"Hypothesis-driven drug testing highlights the KRAS multi-target inhibitor RMC-7977 and the Wnt-targeting tyrosine kinase inhibitor WNTinib as novel strategies to target AC-PC more effectively.\"}]","Paired primary-metastasis patient-derived organoids and mouse models identify phenotypic evolution and druggable dependencies of peritoneal metastasis from appendiceal cancer - abstract | PDF",1790181623,108,[152,156,160,164,168],{"page_no":8,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d8bf456cc6ca6f2e3ad970c996abf2e.webp",983,1272,{"page_no":14,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bae7bd9f6544cb005f38a1a87b9422fe.webp",982,1270,{"page_no":81,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db7bd29b7545bac6613be9df30bd2b34.webp",981,1269,{"page_no":19,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf51147b36ffe75a052dcd7486cc14f8.webp",980,1268,{"page_no":24,"url":169,"width":170,"height":171},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2bed6b269444a5739560d1cd49c03de8.webp",979,1267]